
  
    
      
        
        Open_JJ access_NN is_VBZ gaining_VBG momentum_NN ._. Authors_NNP are_VBP submitting_VBG papers_NNS in_IN ever-increasing_JJ
        numbers_NNS to_TO open-access_JJ journals_NNS ._. Several_JJ prominent_JJ research_NN sponsors_NNS ,_, including_VBG the_DT
        Wellcome_NNP Trust_NNP ,_, the_DT Max_NNP Planck_NNP Society_NNP ,_, the_DT Centre_NNP National_NNP de_IN la_FW Recherche_NNP Scientifique_NNP
        (_( CNRS_NNP )_) ,_, and_CC the_DT Institut_NNP National_NNP de_IN la_FW Santé_NNP et_CC de_IN la_FW Recherche_NNP (_( INSERM_NNP )_) ,_, have_VBP recently_RB
        pronounced_VBN that_IN open_JJ access_NN is_VBZ the_DT best_JJS way_NN for_IN the_DT researchers_NNS they_PRP support_VBP to_TO publish_VB
        their_PRP$ work_NN ._. Several_JJ established_VBN commercial_JJ and_CC not-for-profit_JJ publishers_NNS have_VBP announced_VBN
        plans_NNS to_TO experiment_NN with_IN open-access_JJ models_NNS for_IN some_DT or_CC all_DT of_IN their_PRP$ journals_NNS ._.
        Delighted_NNP and_CC encouraged_VBN ,_, we_PRP gear_VBP up_RP for_IN the_DT launch_NN of_IN 
        PLoS_NNP Medicine_NNP this_DT autumn—the_NN next_JJ step_NN in_IN our_PRP$ efforts_NNS to_TO bring_VB the_DT
        benefits_NNS of_IN open_JJ access_NN to_TO the_DT entire_JJ scientific_JJ and_CC medical_JJ community_NN ._. We_PRP aim_VBP to_TO make_VB 
        PLoS_NNP Medicine_NNP a_DT premier_NN journal_NN ,_, providing_VBG open_JJ access_NN to_TO the_DT best_JJS
        medical_JJ research_NN to_TO researchers_NNS ,_, to_TO physicians_NNS and_CC other_JJ caregivers_NNS ,_, and_CC to_TO the_DT public_NN ._.
        The_DT case_NN for_IN open_JJ access_NN to_TO medical_JJ research_NN is_VBZ even_RB stronger_JJR than_IN it_PRP is_VBZ for_IN basic_JJ
        research_NN in_IN biology_NN ._. There_EX are_VBP more_RBR interested_JJ parties_NNS :_: patients_NNS and_CC their_PRP$ advocates_NNS ;_:
        biotechnology_NN and_CC pharmaceutical_JJ companies_NNS that_WDT develop_VBP drugs_NNS and_CC medical_JJ devices_NNS ;_: doctors_NNS ,_,
        nurses_NNS ,_, and_CC other_JJ healthcare_NN providers_NNS ;_: and_CC health_NN policy-makers_NNS at_IN the_DT national_JJ and_CC
        international_JJ levels_NNS ._. The_DT goal_NN of_IN the_DT medical_JJ research_NN enterprise_NN is—or_NN should_MD
        be—scientifically_RB ,_, ethically_RB ,_, and_CC socially_RB responsible_JJ medicine_NN ,_, which_WDT means_VBZ research_NN that_WDT
        will_MD benefit_VB patients_NNS worldwide_NN ._.
        The_DT reality_NN looks_VBZ somewhat_RB different_JJ ._. Large_JJ investments_NNS into_IN basic_JJ research_NN have_VBP not_RB yet_RB
        lived_VBD up_RP to_TO their_PRP$ full_JJ potential_NN to_TO save_VB lives_NNS and_CC improve_VB their_PRP$ quality_NN ._. Doctors_NNS ,_,
        patients_NNS ,_, and_CC their_PRP$ advocates_NNS do_VBP not_RB have_VB ready_JJ access_NN to_TO the_DT combined_VBN peer-reviewed_JJ
        evidence_NN from_IN medical_JJ research_NN ._. The_DT prices_NNS for_IN the_DT latest_JJS drugs_NNS often_RB put_VBP them_PRP out_IN of_IN reach_NN
        of_IN patients_NNS in_IN poor_JJ countries_NNS or_CC poor_JJ patients_NNS in_IN countries_NNS without_IN universal_JJ healthcare_NN
        systems_NNS ._. Moreover_RB ,_, research_NN focuses_VBZ disproportionately_RB on_IN the_DT potentially_RB lucrative_JJ
        treatments_NNS for_IN diseases_NNS of_IN wealthy_JJ societies_NNS ,_, shortchanging_VBG the_DT poorer_JJR countries_NNS ,_, which_WDT
        bear_VBP the_DT greatest_JJS burden_NN of_IN disease_NN ._.
        A_DT medical_JJ journal_NN by_IN itself_PRP cannot_NN change_NN this_DT reality_NN ._. But_CC with_IN the_DT help_NN of_IN researchers_NNS
        and_CC practicing_VBG physicians_NNS around_IN the_DT world_NN who_WP recognize_VBP the_DT need_NN and_CC opportunity_NN for_IN
        change_NN ,_, we_PRP seek_VBP to_TO create_VB a_DT journal_NN that_WDT promotes_VBZ medical_JJ research_NN and_CC practice_NN that_WDT is_VBZ
        both_DT scientifically_RB rigorous_JJ and_CC compassionate_NN ._.
        Open_JJ access_NN to_TO this_DT literature_NN will_MD strengthen_VB the_DT medical_JJ research_NN community_NN by_IN giving_VBG 
        all_DT stakeholders_NNS free_JJ and_CC immediate_JJ access_NN to_TO the_DT latest_JJS medical_JJ
        research_NN ,_, along_IN with_IN new_JJ and_CC more_RBR powerful_JJ search_NN tools_NNS and_CC links_NNS between_IN the_DT literature_NN
        and_CC other_JJ relevant_JJ information_NN ._.
        
        PLoS_NNP Medicine_NNP will_MD be_VB an_DT international_JJ ,_, modern_JJ ,_, general_JJ medical_JJ journal_NN ,_,
        covering_VBG all_DT areas_NNS in_IN the_DT medical_JJ sciences_NNS ,_, from_IN basic_JJ studies_NNS to_TO large_JJ clinical_JJ trials_NNS and_CC
        cost-effectiveness_JJ analyses_NNS ._. We_PRP will_MD concentrate_VB on_IN human_JJ studies_NNS that_WDT enhance_VB our_PRP$
        understanding_NN of_IN disease_NN epidemiology_NN ,_, etiology_NN ,_, and_CC physiology_NN ;_: the_DT development_NN of_IN
        prognostic_JJ and_CC diagnostic_JJ technologies_NNS ;_: and_CC trials_NNS that_WDT test_NN the_DT efficacy_NN of_IN specific_JJ
        interventions_NNS and_CC those_DT that_WDT compare_VBP different_JJ treatments_NNS ._. We_PRP will_MD publish_VB original_JJ
        research_NN and_CC commentary_NN that_WDT promotes_VBZ translation_NN both_DT of_IN basic_JJ research_NN into_IN clinical_JJ
        investigation_NN and_CC of_IN clinical_JJ evidence_NN into_IN practice_NN ._.
        A_DT truly_RB broad_JJ medical_JJ journal_NN is_VBZ an_DT ambitious_JJ project_NN ,_, but_CC we_PRP want_VBP 
        PLoS_NNP Medicine_NNP to_TO promote_VB an_DT integrated_VBN understanding_NN of_IN the_DT patient—to_NN
        make_NN it_PRP easy_JJ for_IN people_NNS to_TO read_VB outside_IN their_PRP$ specialty_NN area_NN ._. “ Doctors_NNS are_VBP systems_NNS
        biologists_NNS ,_,” as_IN one_CD medical_JJ researcher_NN put_VBD it_PRP ,_, and_CC inspiration_NN can_MD often_RB be_VB found_VBN in_IN
        unfamiliar_JJ territory_NN ._.
        Articles_NNPS published_VBD in_IN 
        PLoS_NNP Medicine_NNP will_MD be_VB rigorously_RB peer-reviewed_JJ ._. Academic_NNP and_CC professional_JJ
        editors_NNS ,_, supported_VBN by_IN expert_NN peer-reviewers_JJ ,_, will_MD select_VB those_DT studies_NNS that_WDT drive_NN research_NN
        forward—in_NN this_DT case_NN ,_, toward_IN medical_JJ applications_NNS and_CC benefits_NNS for_IN patients_NNS ._.
        This_DT issue_NN of_IN 
        PLoS_NNP Biology_NNP contains_VBZ two_CD “ human_JJ” studies_NNS that_WDT met_VBD our_PRP$ criteria_NNS for_IN
        excellence_NN and_CC originality_NN ,_, a_DT paper_NN by_IN Howard_NNP Chang_NNP and_CC colleagues_NNS (_( found_VBD at_IN DOI_NNP :_:
        10_CD ._. 1371_CD /_NN journal_NN ._. pbio_NN ._. 0020007_CD )_) on_IN the_DT microarray_NN analysis_NN of_IN tumors_NNS and_CC one_CD by_IN Sarah_NNP
        Rowland-_NNP Jones_NNP and_CC coworkers_NNS (_( found_VBD at_IN DOI_NNP :_: 10_CD ._. 1371_CD /_NN journal_NN ._. pbio_NN ._. 0020020_CD )_) that_WDT examines_VBZ how_WRB
        HIV_NNP exhausts_NNS the_DT capacity_NN of_IN the_DT immune_JJ system_NN ._. Similar_JJ papers_NNS submitted_VBN in_IN the_DT future_NN will_MD
        be_VB published_VBN in_IN 
        PLoS_NNP Medicine_NNP ,_, alongside_IN studies_NNS that_WDT have_VBP more_RBR direct_JJ implications_NNS for_IN
        clinical_JJ practice_NN ._. This_DT issue_NN also_RB contains_VBZ several_JJ articles_NNS describing_VBG more_RBR basic_JJ advances_NNS
        with_IN medical_JJ implications_NNS :_: a_DT study_NN by_IN Terry_NNP van_NN Dyke_NNP and_CC colleagues_NNS (_( found_VBD at_IN DOI_NNP :_:
        10_CD ._. 1371_CD /_NN journal_NN ._. pbio_NN ._. 0020022_CD )_) describing_VBG a_DT new_JJ mouse_NN model_NN for_IN breast_NN cancer_NN ,_, a_DT report_NN on_IN a_DT
        novel_NN approach_NN to_TO drug_NN synthesis_NN by_IN Chaitan_NNP Khosla_NNP and_CC coworkers_NNS (_( found_VBD at_IN DOI_NNP :_:
        10_CD ._. 1371_CD /_NN journal_NN ._. pbio_NN ._. 0020031_CD )_) ,_, and_CC an_DT article_NN by_IN Stephen_NNP Dowdy_NNP et_CC al_NN ._. (_( found_VBD at_IN DOI_NNP :_:
        10_CD ._. 1371_CD /_NN journal_NN ._. pbio_NN ._. 0020036_CD )_) on_IN targeted_VBN modulation_NN of_IN p_NN 53_CD activity_NN ._. 
        PLoS_NNP Biology_NNP will_MD continue_VB to_TO solicit_VB and_CC publish_VB such_JJ articles_NNS ,_, but_CC we_PRP
        will_MD bring_VB them—and_NN similar_JJ ones_NNS published_VBD elsewhere—to_NN the_DT attention_NN of_IN the_DT readers_NNS of_IN 
        PLoS_NNP Medicine_NNP ._.
        Like_IN 
        PLoS_NNP Biology_NNP ,_, 
        PLoS_NNP Medicine_NNP must_MD be_VB a_DT community_NN journal_NN to_TO achieve_VB its_PRP$ goals_NNS ._. If_IN you_PRP
        are_VBP a_DT researcher_NN or_CC an_DT individual_NN anywhere_RB in_IN the_DT world_NN who_WP has_VBZ a_DT stake_NN in_IN medical_JJ research_NN
        and_CC if_IN the_DT goals_NNS of_IN 
        PLoS_NNP Medicine_NNP outlined_VBD here_RB resonate_VB with_IN you_PRP ,_, please_VB contact_NN us_PRP ._. 
        PLoS_NNP Medicine_NNP will_MD accept_VB submissions_NNS beginning_VBG in_IN April_NNP 2004_CD ,_, and_CC we_PRP are_VBP
        looking_VBG for_IN advocates_NNS who_WP will_MD help_VB to_TO spread_VB the_DT word_NN about_IN open_JJ access_NN and_CC 
        PLoS_NNP Medicine_NNP in_IN the_DT global_JJ medical_JJ community_NN and_CC for_IN investigators_NNS who_WP
        will_MD submit_VB excellent_JJ research_NN ,_, review_NN submitted_VBD articles_NNS ,_, and_CC contribute_VB editorials_NNS and_CC
        commentaries_NNS ._. 
        PLoS_NNP Medicine_NNP is_VBZ and_CC will_MD stay_VB a_DT work_NN in_IN progress_NN ,_, and_CC we_PRP want_VBP to_TO consult_VB
        with_IN as_IN many_JJ people_NNS as_IN possible_JJ ,_, both_DT before_IN the_DT launch_NN and_CC as_IN 
        PLoS_NNP Medicine_NNP evolves_NNS ._. Sign_NNP up_IN to_TO join_VB the_DT 
        PLoS_NNP Medicine_NNP community_NN at_IN http_NN :_: /_NN /_NN www_NN ._. plos_NNS ._. org_NN /_NN medicine_NN and_CC help_VB us_PRP to_TO
        make_VB the_DT best_JJS of_IN medical_JJ research_NN and_CC practice_VB accessible_JJ to_TO a_DT global_JJ audience_NN ._.
      
    
  
